Presentation is loading. Please wait.

Presentation is loading. Please wait.

A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter  Norihiko Ikeda, MD, PhD, Junichi Maeda, MD, Koichi Yashima, MD, Masahiro.

Similar presentations


Presentation on theme: "A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter  Norihiko Ikeda, MD, PhD, Junichi Maeda, MD, Koichi Yashima, MD, Masahiro."— Presentation transcript:

1 A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter 
Norihiko Ikeda, MD, PhD, Junichi Maeda, MD, Koichi Yashima, MD, Masahiro Tsuboi, MD, Harubumi Kato, MD, PhD, Soichi Akada, MD, PhD, Shinya Okada, MD, PhD  The Annals of Thoracic Surgery  Volume 78, Issue 3, Pages (September 2004) DOI: /j.athoracsur

2 Fig 1 Thin section computed tomographic scan of lung cancer depicting solid attenuation and ground-glass opacity (GGO). The largest area of tumor (solid line) and solid attenuation (dotted line) were decided based on this film. The proportion of GGO area to the entire tumor was defined; GGO ratio = (maximum GGO − maximum consolidation)/maximum GGO. Max GGO (solid arrow); Max consolidation (dotted arrow). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

3 Fig 2 Five-year survival rate of adenocarcinoma less than or equal to 2 cm was 88.0%. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

4 Fig 3 Five-year survival rate according to tumor size. Less than or equal to 1 cm = 96.7%, 1.0–1.5 cm = 81.6%, 1.5–2.0 cm = 84.4%. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

5 Fig 4 Five-year survival rate according to the proportion of ground-glass opacity (GGO) area. A GGO dominant patient indicated a 100% 5-year survival, whereas patients exhibiting a GGO area less than 50% indicated an 83.9% 5-year survival. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

6 Fig 5 Five-year survival rate according to the Noguchi classification. Noguchi A, B indicated a 100% 5-year survival, type C indicated a 97.4% 5-year survival, and types D, E, and F, indicated a 67.1% 5-year survival, respectively. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )


Download ppt "A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter  Norihiko Ikeda, MD, PhD, Junichi Maeda, MD, Koichi Yashima, MD, Masahiro."

Similar presentations


Ads by Google